Keryx Gets Back on the Map
Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) has not been a household name in biotech investing, but the move on news on Monday has put the company on the map. After shares ...Read Full Story »
Posts related to ‘dialysis drugs’
Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (9971)
- Accounting (513)
- Active Trader (4413)
- Aerospace & Defense (230)
- Alternative Energy (1061)
- Analyst Calls (5084)
- Autos (1477)
- Banking & Finance (3795)
- Bankruptcy (283)
- Buffett (339)
- Calendar (421)
- Casinos & Hotels (99)
- Commodities & Metals (1360)
- Consumer Product (795)
- Corporate Governance (1997)
- Dividends & Buybacks (929)
- Earnings (4156)
- Economy (3709)
- Editor's Picks (516)
- ETFs & Mutual Funds (825)
- General (3837)
- Healthcare (1435)
- Housing (1042)
- Industrials (632)
- Infrastructure (605)
- International Markets (4178)
- Internet (2197)
- IPOs & Secondaries (1653)
- Jobs (158)
- Labor (657)
- Media (4207)
- Mergers & Acquisitions (2228)
- Oil & Gas (2578)
- Personal Finance (308)
- Politics (825)
- Polls (34)
- Regulation (1164)
- Retail (2589)
- Rumors (1093)
- Services (299)
- Special Report (377)
- Technology (3828)
- Telecom & Wireless (1693)
- Transportation (581)
- Value Investing (766)
